10x Genomics, Inc.
US ˙ NasdaqGS ˙ US88025U1097

SecurityTXG / 10x Genomics, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership317,643 shares
Latest Disclosed Value $ 6,743,561
Invesco Ltd. reports 4.98% decrease in ownership of TXG / 10x Genomics, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 317,643 shares of 10x Genomics, Inc. (US:TXG) valued at $6,743,561 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 334,300 shares of 10x Genomics, Inc.. This represents a change in shares of -4.98% during the quarter. The current value of the position is $10,215,399 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 317,643 -16,657 -4.98 6,744 23.68 0.0001
2026-02-19 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 334,300 58,537 21.23 5,452 69.16 0.0008
2025-11-13 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 275,763 74,024 36.69 3,224 37.97 0.0005
2025-08-13 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 201,739 10,407 5.44 2,336 39.88 0.0004
2025-05-12 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 191,332 73,265 62.05 1,670 -1.47 0.0003
2025-02-13 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 118,067 21,134 21.80 1,695 -22.53 0.0003
2024-11-12 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 96,933 -3,485 -3.47 2,189 12.03 0.0004
2024-08-13 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 100,418 16,607 19.81 1,953 -37.90 0.0004
2024-05-14 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 83,811 -2,251,127 -96.41 3,145 -97.59 0.0007
2024-02-13 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 2,334,938 108,472 4.87 130,663 42.27 0.0311
2023-11-13 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 2,226,466 354,680 18.95 91,842 -12.13 0.0247
2023-08-11 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 1,871,786 204,123 12.24 104,521 12.34 0.0274
2023-05-12 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 1,667,663 1,590,355 2,057.17 93,039 3,202.73 0.0260
2023-02-13 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 77,308 -53,570 -40.93 2,817 -24.42 0.0008
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 130,878 2,482 1.93 3,727 -35.84 0.0012
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 128,396 -5,695 -4.25 5,809 -43.05 0.0018
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 134,091 -47,119 -26.00 10,200 -62.21 0.0026
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 181,210 -370,446 -67.15 26,993 -66.39 0.0065
2021-11-15 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 551,656 -656,798 -54.35 80,310 -66.06 0.0204
2021-08-17 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 1,208,454 -94,878 -7.28 236,640 0.31 0.0582
2021-05-17 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 1,303,332 198,217 17.94 235,904 50.75 0.0630
2021-02-16 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 1,105,115 -687,718 -38.36 156,484 -29.99 0.0455
2020-11-16 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 1,792,833 478,366 36.39 223,530 90.41 0.0756
2020-08-14 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 1,314,467 59,445 4.74 117,395 50.10 0.0420
2020-05-15 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 1,255,022 790,769 170.33 78,213 120.95 0.0329
2020-02-14 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 464,253 103,661 28.75 35,399 94.78 0.0110
2019-11-14 2019-09-30 13F 10X GENOMICS CL A COM 88025U109 360,592 360,592 18,174 0.0048
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.